REQUEST A DEMO
Total
USD $0.00
Search more companies

Astrazeneca do Brasil Ltda. (Brazil)

Main Activities: Medicinal and Botanical Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences | Marketing Research and Public Opinion Polling | Office Administrative Services | Other Support Services
Full name: Astrazeneca do Brasil Ltda. Profile Updated: March 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Portuguese Download a sample report

AstraZeneca is a company result form a fusion of Astra AB and Zeneca Group PLC, decided by both directories in 1998. In Brazil, AstraZeneca was created in August, 1999, with headquarters in Cotia, city of Sao Paulo state. The company operates woth 800 employees in two independet business unities: Pharma Division and Oncology Division. Is considered the second best company in the pharmaceutical sector by Melhores e Maiores Magazine, from Exame, of 2009.

Headquarters
Rodovia Raposo Tavares S/N, Km. 26.9, Granja Viana
Cotia; Sao Paulo; Postal Code: 06707000

Contact Details: Purchase the Astrazeneca do Brasil Ltda. report to view the information.

Website: http://www.astrazeneca.com.br

Basic Information
Total Employees:
Purchase the Astrazeneca do Brasil Ltda. report to view the information.
Outstanding Shares:
Purchase the Astrazeneca do Brasil Ltda. report to view the information.
Registered Capital:
Purchase the Astrazeneca do Brasil Ltda. report to view the information.
Financial Auditors:
Purchase the Astrazeneca do Brasil Ltda. report to view the information.
Incorporation Date:
April 03, 1989
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Astrazeneca do Brasil Ltda. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BRL. Absolute financial data is included in the purchased report.
Net sales revenue
20.59%
Total operating revenue
20.59%
Operating profit (EBIT)
33.4%
EBITDA
33.2%
Net Profit (Loss) for the Period
28.17%
Total assets
12.2%
Total equity
12.85%
Operating Profit Margin (ROS)
2.26%
Net Profit Margin
1.04%
Return on Equity (ROE)
4.72%
Quick Ratio
-0.01%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?